Project overview Targeted molecular radiotherapy delivered by radiolabelled anti-CD66 as the only conditioning prior to autologous stem cell transplantation for AL-amyloidosis, a Phase I/IIa trial. Staff Lead researchers KO Dr Kim Orchard Connect with Kim Email: [email protected] Research outputs